Coagulation optimization for DOC removal: pilot-scale analysis of UF fouling and disinfection byproduct formation potential

A pilot-scale study was performed to evaluate a coagulant dose which had been optimized for biopolymer (i.e., foulant) removal on subsequent ultrafiltration (UF) fouling, as well as disinfection by-product (DBP) precursor removal. Polyaluminum chloride (PACl) dosages were selected based on a point of diminishing returns for biopolymer removal (0.5 mg/L) and directly compared to that applied at full-scale (6 mg/L). Membrane fouling (reversible and irreversible) was measured as resistance increase over a 48 hour filtration period. DBP formation potential (total trihalomethanes (TTHMs), haloacetic acids (HAA₉) and total adsorbable organic halides (AOX)) were measured in both raw and treated waters. Results of the study indicate that application of a PACl dose optimized for biopolymer reduction (0.5 mg/L) resulted in 65% less irreversible UF fouling when compared to 6 mg/L. The addition of PACl prior to the membrane resulted in up to a 14% reduction in DBP precursors relative to the UF membrane alone. A similar level of DBP precursor reduction was achieved for both 0.5 and 6 mg/L dosages. The results have implications for cost savings, which may be realized due to decreased chemical use, as well as increased membrane life associated with lower irreversible fouling rates.